N. Collette

Synthetic Alkylamide 15 and the Required Structural Components for Mast Cell Inhibition.

N. Collette, 2017 .

Pilot study of amphotericin B entrapped in sonicated liposomes in cancer patients with fungal infections.

J. Sculier, J. Klastersky, F. Meunier, 1988, European journal of cancer & clinical oncology.

Mast cell degranulation and calcium influx are inhibited by an Echinacea purpurea extract and the alkylamide dodeca-2E,4E-dienoic acid isobutylamide.

N. Cech, D. Todd, E. Mackey, 2018, Journal of ethnopharmacology.

Tissue concentrations and bioactivity of amphotericin B in cancer patients treated with amphotericin B-deoxycholate

F. Meunier, P. van der Auwera, P. Auwera, 1989, Antimicrobial Agents and Chemotherapy.

Amphotericin B Encapsulated in Liposomes Administered to Cancer Patients a

J. Sculier, J. Klastersky, F. Meunier, 1988, Annals of the New York Academy of Sciences.

High-performance liquid chromatographic determination of amphotericin B in human serum.

J. Sculier, F. Meunier, N. Collette, 1987, Journal of chromatography.

Hydrolysis of the C-terminal octapeptide of cholecystokinin by rat kidney membranes: characterization of the cleavage by solubilized endopeptidase-24.11.

M. Deschodt-Lanckman, N. Collette, T. Najdovski, 1985, Life sciences.

Tissue distribution and bioactivity of amphotericin B administered in liposomes to cancer patients.

J. Sculier, F. Meunier, P. van der Auwera, 1991, The Journal of antimicrobial chemotherapy.